• UCLA Health
  • myUCLAhealth
  • School of Medicine
Institute of Urologic Oncology

UCLA Institute of Urologic Oncology

Institute of Urologic Oncology
  • About Us
    • Director's Welcome
    • Board of Directors
    • IUO in the News
    • Why Choose the UCLA IUO
    • Support the IUO
    • Contact Us
    • The Wasserman Building
    • Maps and Directions
    • IUO Membership Information
    • Administrative & Research Staff
    • Positions Available
  • Clinical Programs
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
    • Testicular Cancer
    • Integrated Cancer Program
    • Cancer Genetic Risk Assessment Program
    • Second Opinion for Cancer
  • Research Programs
    • Clinical Trials
    • Faculty Labs
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
    • LuPSMA Risk Calculator
    • PSMA Risk Calculator
    • SPORE In Prostate Cancer
    • Webinars / Videos
  • Clinical Trials
    • What Is a Clinical Trial?
    • Who Should Consider Clinical Trials & Why
    • Bladder Cancer Clinical Trials
    • Kidney Cancer Clinical Trials
    • Prostate Cancer Clinical Trials
    • Testicular Cancer Clinical Trials
    • Clinical Research Team
    • IUO Membership Study Information
  • For Patients
    • Contact Us
    • Clinical Updates
    • Maps and Directions
    • myUCLAhealth
    • Webinars / Videos
  • Fellowship
    • Current Fellows
    • Former Fellows
    • Fellow Testimonials
    • UCLA Health Aerial Tour
    • Webinars/Videos
  • For Healthcare Professionals
    • How to Refer a Patient
    • Lectures & Conferences
    • CTSI Distinguished Speaker Seminar Series
    • DGSOM Research Seminars
    • DGSOM Events
    • JCCC Seminars
    • Researcher Resources
    • SPORE Lectures
  • Expert Team
    • Board of Directors
    • Medical Oncology
    • Nuclear Medicine
    • Pathology
    • Radiation Oncology
    • Radiology
    • Urologic Oncology
    • Research Faculty
    • Emeritus Faculty
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

UCLA Institute of Urologic Oncology

For Patients

For Patients

For Patients

  • Contact Us
  • Clinical Updates
  • Maps and Directions
  • myUCLAhealth
  • Webinars / Videos
  • Contact Us
  • Clinical Updates
  • Maps and Directions
  • myUCLAhealth
  • Webinars / Videos
  1. Home
  2. Institute of Urologic Oncology
  3. For Patients
  4. Webinars / Videos

Webinars

Share this
Request An Appointment

Phone: (310) 794-7700

Webinars & Videos

Join the conversation on Twitter at @UCLAHealth with hashtag #UCLAMDChat Tweets about "#UCLAMDChat"

Emmi Program for Patient Teaching & Education

Welcome to Emmi, our interactive patient education system. For more information >

Care and Management

PET Scan (Positron Emission Tomography) 

UCLA Radiation Oncology Patient Education Video – What to expect throughout your treatment

Prostate Health Quiz – This quiz will help you build your knowledge of steps you can take to prevent prostate cancer:  

Conditions Videos

Bladder Cancer

Kidney Cancer

Prostate Cancer


By Organ - Bladder

Innovations in Treating Bladder and Kidney Cancer

View WebinarKarim Chamie, MD, MSHS, Director of the IUO’s Bladder Cancer Program, has primary research interests in health services research and clinical trials in bladder cancer. Watch Video >


By Organ - Kidney

Aggressive Systemic and Multi-Modal Therapy to Treat Metastatic Kidney Cancer

View Webinar

UCLA oncologist Sandy Liu, MD, talked about UCLA’s multi-disciplinary treatment approach to target advanced kidney cancer. The team approaches each case individually with the hope of eradicating all disease with aggressive systemic therapy and, when feasible, adding multi-modal therapy to consolidate residual disease. Watch Video >


By Organ - Prostate

‘Friends’ star James Michael Tyler, who played Gunther, has prostate cancer NBC Today

View Webinar

Feature on James Michael Tyler, the actor who played sarcastic coffee shop employee Gunther on “Friends”, includes interview with Matthew Rettig, MD, Medical Director, Prostate Cancer Program of the Institute of Urologic Oncology at UCLA and member of the Jonsson Comprehensive Cancer Center. Read the story >


Detecting prostate cancer with PSMA PET: FDA Approval 

View Webinar

When David McEowen discovered he had a recurrence of prostate cancer, his physicians used PSMA PET as part of his treatment plan.  Today, he is cancer-free.  The University of California’s two nationally ranked medical centers, UCSF and UCLA are the only two medical centers in the United States that can offer a new imaging technique for prostate cancer - PSMA PET - to the public through FDA approval. A limited number of other U.S. medical centers are currently using PSMA as an investigational technique, generally as part of a clinical trial.  However, more hospitals will have the opportunity to adopt the technology after applying for expedited FDA approval, which is now possible as a result of the initial FDA approval gained by UCLA and UCSF. Watch Video >


Precision Oncology Program for Cancer of the Prostate (POPCaP)  

View Webinar

Medical Director of the Institute of Urologic Oncology Prostate Cancer Program Dr. Matthew Rettig discusses POPCaP and his work involving the health of veterans with prostate cancer and ongoing clinical trials going on exclusively within the Veterans Health Administration (VA) system. The Precision Oncology Program for Cancer of the Prostate (POPCaP), a partnership between the VA and the Prostate Cancer Foundation (PCF) to create a system of excellence for prostate cancer in VA is focused on delivering precision oncology to veterans throughout the United States with a clinical emphasis on advanced prostate cancer. The goal is a development of a molecular biomarker, most likely a genetic sequence through next-generation sequencing, so that a match can be made between a specific genetic lesion and a specific therapy. This genomic sequencing is directing clinicians towards what he calls precision medicine or being able to tailor a specific therapy for that individual person. Watch Video >


Equipment with a built-in MRI allows doctors to better see internal anatomy

View Webinar

A new advance in radiation-therapy equipment is giving physicians the ability to better visualize tumors and internal anatomy, allowing more accurate delivery of necessary treatments.  The equipment, called the MRIdian LINAC, is an improvement over older technologies, because it uses a built-in MRI to guide radiation treatment in real time, explains Chief of the Genitourinary Oncology Service at the David Geffen School of Medicine at UCLA and Member of the UCLA Institute of Urologic Oncology Amar U. Kishan, MD. Read More > Watch Video >


Stereotactic Body Radiotherapy for Prostate Cancer: Amar Kishan, MD

View Webinar

Chief of the Genitourinary Oncology Service at the David Geffen School of Medicine at UCLA and Member of the UCLA Institute of Urologic Oncology Amar U. Kishan, MD, tne rationale, logistics and data for stereotactic body radiotherapy for prostate cancer, and how technological advancements have helped to condense treatment schedules. Watch Video >


New Method for Detecting and Managing Prostate Cancer

View Webinar

UCLA urologist Robert Reiter, MD, presented a live-streaming webinar to discuss Ga-PSMA PET CT, a new method for detection and visualization of metastatic prostate cancer not previously visible with conventional and molecular imaging techniques. Ga-PSMA PET CT is now offered at UCLA and aims to improve management of recurrent and high-risk cancers. Watch Video >
Note: Investigational agent. Currently not approved by FDA for imaging prostate cancer.


Curing Prostate Cancer With Ultrasound: HIFU Arrives at UCLA

View Webinar

UCLA urologist Leonard Marks, MD, presented a live-streaming webinar to discuss HIFU (high intensity focused ultrasound). Watch Video >


MRI/Ultrasound Fusion to Improve Accuracy of Prostate Biopsy

View Webinar

On Wednesday, April 6, 2016, 11:30 am PST, UCLA urologist Leonard Marks, MD, presented a live-streaming webinar to discuss the benefits of combining the sensitivity of MRI with the convenience of ultrasound to greatly increase accuracy of prostate biopsy. MRI fusion with ultrasound provides the ability to map and target biopsies.
Watch Video >


Provenge Immunotherapy for Prostate Cancer

View Webinar

On Wed, Mar 11, 2015 at 11:30 AM PDT, Allan J. Pantuck, MD, MS, FACS, professor in the UCLA Department of Urology presented a live-streaming webinar to discuss the use of Provenge in the treatment of prostate cancer. Dr. Pantuck discussed the background and rationale for the use of immune-based therapies in the treatment of cancer and the indications, benefits and side effects of Provenge, an FDA-approved treatment for advanced prostate cancer that utilizes the patient’s genetically engineered immune cells. What is Provenge? Provenge Vaccine for Prostate Cancer at UCLA >
Watch Video >


Robots Advance the Reach of Urologic Surgeons

View Webinar

UCLA urologist Robert Reiter, MD - Surgeons increasingly are using robotic surgery to operate on patients, resulting in less blood loss, less pain and faster recovery. Since 2003, UCLA urologic surgeons have performed more than 3,000 procedures robotically to treat prostate, bladder and kidney cancer.
Watch Video >


By Organ - Testicular

Testicular Cancer: What You Really Need to Know

View Webinar

UCLA Urologist Mark Litwin, MD, presented a live-streaming webinar to discuss the basics of testicular cancer diagnosis and treatment. He presented a path to cure for almost all men.
Watch Video >


Testicular Cancer: Facts and Fictions

View Webinar

On April 22, 2015, UCLA urologist, Dr. Mark S. Litwin, presented a live-streaming webinar to discuss common misconceptions about testicular cancer. He also presented an insider’s view of what to do if you have a lump in the testicle or have been told you have testicular cancer.
Watch Video >


Testicular Cancer: Survivor Story

Testicular cancer survivor and pro baseball player strives to raise awareness about the condition. UCLA Health Connect for the video story > To learn more about testicular cancer and the UCLA Health team that treats it, visit the UCLA Health Testicular Cancer Program.


Testicular Cancer with Dr. Mark Litwin (NBCLX)

UCLA Urologist Mark Litwin, MD, presents his own experience and recommendations.  "If you find something you think is suspicious -- a lumpy bumpy area inside the testicle -- get yourself to a good doctor... a urologist typically and then he or she can make a diagnosis." Watch Video >


Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest